HAMİT HAKAN ALP, FATMA ZÜHAL UMUDUM, EBUBEKİR BAKAN

Beta-fibrinogen 455 G/A and angiotensin converting enzyme ins/del polymorphisms in patients with lung cancer

In our study we have investigated polymorphism due to base change occurring at -455 position of promoter region of β- fibrinogen synthesizing gene in lung cancer patients. In addition, we have also investigated insertion/deletion (I/D) polymorphism in intron 16 of Angiotensin Converting Enzyme (ACE) gene, located on chromosome 17q23. Aim of our study is to determine polymorphisms of β-fibrinogen -455 G/A and ACE I/D in patients with lung cancer and healthy control and to determine whether these polymorphisms contribute to the formation of lung cancer. In addition, we aimed to clarify whether β-fibrinogen -455 G/A polymorphism effect the level of fibrinogen synthesis in patients with lung cancer. Samples in our study was obtained from 100 patients with lung cancer and 100 healthy volu nteers. Plasma fibrinogen levels were measured with ELISA method. Polymorphism analyses were determined with PCR-reverse hybridization method. Results of our study revealed that fibrinogen levels of patients with lung cancer were significantly higher than healthy control group (p

PDF

___

Cheng ZS, Ma RL, Tan WJ, Zhang L, Tan QY. Lack of association between ACE insertion/deletion polymorphism and lung cancer: A meta-analysis. J Renin-Angio-Aldo S 2015; 16: 453-158.

Cheon KT, Choi KH, Lee HB, Park SK, Rhee YK, Lee YC. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000; 178: 351-360.

Yaren A, Oztop I, Turgut S, Turgut G, Degirmencioglu S, Demirpence M. Angiotensinconverting enzyme gene polymorphism is associated with anemia in non-small-cell lung cancer. Exp Biol Med 2008; 233: 32-37.

Nacak M, Nacak I, Sanli M, Ozkur M, Pektas M, Aynacioglu AS. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey. Cancer genetics and cytogenetics 2010; 198: 22-26.

Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 2004; 23: 317-329.

Yoshiji H, Kuriyama S, Fukui H. Angiotensin-Iconverting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biology 2002; 23: 348- 356.

Abali H, Güllü I, Haznedaroğlu I, Erman M, Tekuzman G. Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Medical Hypotheses 2002; 59: 344- 348.

Kaufman KM, Kelly J, Gray-McGuire C, Asundi N, Yu H, Reid J, et al. Linkage analysis of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and systemic lupus erythematosus. Molecular and cellular endocrinology 2001; 177: 81-85.

Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer? Trends in endocrinology and metabolism: TEM 2005; 16: 293-299.

Stroth U, Unger T. The renin-angiotensin system and its receptors. Journal of cardiovascular pharmacology 1999; 33 Suppl 1: 21-28; discussion 41-43.

Wang J, Han T, Chen X, Tang X. The correlation study of beta-fibrinogen gene polymorphisms and plasma fibrinogen concentration in patients with colorectal cancer. China Oncology 2015; 25: 807- 811.

Vossen CY, Hoffmeister M, Chang-Claude JC, Rosendaal FR, Brenner H. Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk. J Clin Oncol 2011; 29: 1722-1727.

Brown ET, Fuller GM. Detection of a complex that associates with the B beta fibrinogen G(- 455)-A polymorphism. Blood 1998; 92: 3286- 3293.

Lu D, Chen X, Huang M, Xu B, Ding J. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study. Online Journal of Biological Sciences 2007; 7: 8-11.

Guo QQ, Zhang B, Dong X, Xie QP, Guo EQ, Huang H, et al. Elevated Levels of Plasma Fibrinogen in Patients With Pancreatic Cancer Possible Role of a Distant Metastasis Predictor. Pancreas 2009; 38: 75-79.

Takeuchi H, Ikeuchi S, Kitagawa Y, Shimada A, Oishi T, Isobe Y, et al. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroen Hepatol 2007; 22: 2222-2227.

Polterauer S, Grimm C, Seebacher V, Concin N, Marth C, Tomovski C, et al. Plasma Fibrinogen Levels and Prognosis in Patients with Ovarian Cancer: A Multicenter Study. Oncologist 2009; 14: 979-985.

Polterauer S, Seebacher V, Hefler-Frischmuth K, Grimm C, Heinze G, Tempfer C, et al. Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer. Am J Obstet Gynecol 2009; 200: 647.

Yamashita H, Kitayama J, Taguri M, Nagawa H. Effect of Preoperative Hyperfibrinogenemia on Recurrence of Colorectal Cancer Without a Systemic Inflammatory Response. World J Surg 2009; 33: 1298-1305.

Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 2013; 11: 223-233.

Donati MB. Cancer and Thrombosis - from Phlegmasia Alba Dolens to Transgenic Mice. Thromb Haemostasis 1995; 74: 278-281.

Trousseau A. Phlegmasia alba dolens. n Clinique Medicale de l'Hotel-Dieu de Paris Journal 1865; 3: 695-727. 21. Dvorak HF, Senger DR, Dvorak AM. Fibrin as a Component of the Tumor Stroma - Origins and Biological Significance. Cancer Metast Rev 1983; 2: 41-73.

Xu H, Spitz MR, Amos CI, Shete S. Complex segregation analysis reveals a multigene model for lung cancer. Human genetics 2005; 116: 121-127.

Torre LA, Bray F, Siegel RL, Ferlay J, LortetTieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians 2015; 65: 87- 108.

Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. The Journal of clinical investigation 1990; 86: 1343-1346.

Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991; 266: 15377-15383.

Costerousse O, Jaspard E, Allegrini J, Wei L, Alhencgelas F. The Angiotensin-I-Converting Enzyme (Kininase-Ii) - Molecular and Physiological-Aspects. Cr Soc Biol 1992; 186: 586-598.

Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000; 96: 3302- 3309.

Akl EA, Rohilla S, Barba M, Sperati F, Terrenato I, Muti P, et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review. CancerAm Cancer Soc 2008; 113: 1685-1694.

Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990; 265: 6389-6393.

Connor JM, Fowkes FGR, Wood J, Smith FB, Donnan PT, Lowe GDO. Genetic-Variation at Fibrinogen Loci and Plasma-Fibrinogen Levels. J Med Genet 1992; 29: 480-482.

Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894- 1904.

Kim I, Kim HG, Kim H, Kim HH, Park SK, Uhm CS, et al. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietinrelated protein that prevents endothelial-cell apoptosis. Biochem J 2000; 346: 603-610.

Sheng LM, Luo M, Sun XJ, Lin NM, Mao WM, Su D. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. Int J Cancer 2013; 133: 2720-2725.

Yokota J, Shiraishi K, Kohno T. Genetic basis for susceptibility to lung cancer: Recent progress and future directions. Advances in cancer research 2010; 109: 51-72.

Cagle PT, Allen TC, Dacic S, Beasley MB, Borczuk AC, Chirieac LR, et al. Revolution in lung cancer: new challenges for the surgical pathologist. Archives of pathology & laboratory medicine 2011; 135: 110-116.

Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer-Am Cancer Soc 2008; 113: 5-21.

Davidson MR, Gazdar AF, Clarke BE. The pivotal role of pathology in the management of lung cancer. J Thorac Dis 2013; 5: 463-478.

Fong K, Bowman R, Abraham R, Windsor M, Pratt G, Fielding D, et al. Queensland Integrated Lung Cancer Outcomes Project (QILCOP): 2000- 2003. Lung Cancer-J Iaslc. 2005;49:S201-S2.

Başkanlığı TCSBHSKKD. Kanser İnsidansı 2013. Available from: http://kanser.gov.tr/Dosya/2016_Haberler/KA NSER_iNSiDANSLARi_2013_kisa_rapor.pdf.

International A, for, Research, on, Cancer, IARC. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 2012 [cited 2016 january]. Available from: http://globocan.iarc.fr/Pages/online.aspx.